Abstract:Background:The intestine is now known as a key metabolic organ that is involved in the development of metabolic complications in obesity and diabetes.Studies on obese and insulin resistant rodents and humans show that small intestine develops a local insulin resistance state, an altered lipid and lipoprotein metabolism, low-grade inflammation and increased paracellular permeability.Because of the complex microenvironment surrounding intestinal epithelial cells, it is not clear so far whether intestinal dyshomeostasis is primarily induced by exogenous obesity-related factors or is a response to obesity-related endogenous alterations in the host.Objectives: To assess the impact of obesity-related endogenous factors (i.e.hyperglycemia, dyslipidemia, inflammation or endocannabinoid system activation) on intestinal epithelial functions in organoids.Methods: Organoids, derived from male C57BL/ 6 mouse duodenum, were incubated 24h with the following conditions: a) inflammatory state (20 mM LPS, 100 nM TNF a, IL-1b and IFNg); b) dyslipidemia (5 mM vs. 2 mM of Palmitate:Oleate [2:1] in 1 mM BSA); c) hyperglycemia (2600 mg/L vs. 1000 mg/L); and d) endocannabinoid system activators(ACEA and Noladin).Results: Incubation of organoids with insulin (30 min, EC50=10 nM) induced a dose-response activation of Akt Ser473 phosphorylation.Insulin signaling was blunted by the induction of an inflammatory state (-50%, p<0.05) and by free fatty acid levels similar to dyslipidemia (-37%, p<0.05) while hyperglycemia only reduce insulin sensitivity at much higher glucose levels than observed in diseases [>4500 mg/L].These obesity-related endogenous factors also impact the expression of several genes related to the epithelial cell functions in the intestine.The inflammatory state increase expression of genes related to intestinal paracellular permeability ( Tjp, Ocln, Marveld2), immune and inflammatory response (Def20, Muc1, Lyz2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1/2, Acss2, Acaca) and nutrient transport (Slc2a2/5, Slc5a1, Abcg5/8, Fabp2).Endocannabinoid system activation also led to several changes in the expression of genes related to intestinal paracellular permeability ( Tjp, Marveld2), immune and inflammatory response (Def20, Lyz2, Muc2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1, Fabp2) and glucose homeostasis (Gip, Slc2a2/5, Slc5a1) but with divergent effects according to the ligands (ACEA vs. Noladin).Conclusion: This study demonstrates that basolateral exposure of small intestine epithelium organoids to obesity-related factors impact the ability of the cell to signal insulin and suggest the development of alterations in other key intestinal functions.Overall, this study suggests that the host metabolic states may represent an important mechanism in the development of small intestine alteration in obesity.

Intestinal Stem Cell-Derived Enteroids from Morbidly Obese Patients Preserve Obesity-Related Phenotypes: Elevated Glucose Absorption and Gluconeogenesis.

Obesity Phenotypes Are Preserved in Intestinal Stem Cell Enteroids from Morbidly Obese Patients

Small intestine-targeted endoscopic bariatrics: current status and future perspectives.

Intestinal epigenomic alterations are associated with a dysregulated nutrient absorption phenotype in obesity

Tu1206 EFFECT OF BACILLUS SUBTILIS AND ENTEROCOCCUS FAECALIS SUPERNATANT ON SERT EXPRESSION IN ENTEROCYTES AND RAT INTESTINAL TISSUES

Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice

Beta-cell mass adaptation to ileum nutrient flow. An experimental model

Intestinal epithelial adaptations to vertical sleeve gastrectomy defined at single-cell resolution

818-P: Chronic Oral Polymeric Duodenal Exclusion Therapy Has Profound Metabolic Benefits in a T2D Rat Model and Affects Duodenal Morphological Enteroplasticity Similar to RYGB surgery: Implications for T2D Therapy

Type 1 diabetes human enteroid studies reveal major changes in the intestinal epithelial compartment

A Planar Culture Model of Human Absorptive Enterocytes Reveals Metformin Increases Fatty Acid Oxidation and Export

Different effects of bariatric surgery on epigenetic plasticity in skeletal muscle of individuals with and without type 2 diabetes

Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity

Enhanced Glucose Homeostasis Via Clostridium Symbiosum-Mediated Glucagon-Like Peptide 1 Inhibition of Hepatic Gluconeogenesis in Mid-Intestinal Bypass Surgery.

Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice

Bariatric surgery alters mitochondrial function in gut mucosa

Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis

Multi-omic phenotyping reveals host-microbe responses to bariatric surgery, glycaemic control and obesity

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

Hypoabsorptive surgeries cause limb-dependent changes in the gut endocannabinoidome and microbiome in association with beneficial metabolic effects

Nutrient Transporter Expression in the Jejunum in Relation to Body Mass Index in Patients Undergoing Bariatric Surgery